相关论文: Accelerator Based Production of $^{225}$Ac for Can…
There has been growing clinical evidence of the value of targeted alpha therapy for treatment of several cancers. The work has been slowed by the lack of availability of the key alpha emitting isotopes, especially Ac-225. Until this time,…
Cross sections for the formation of 225,227-Ac, 223,225-Ra, and 227-Th via the proton bombardment of natural thorium targets were measured at a nominal proton energy of 800 MeV. No earlier experimental cross section data for the production…
Cross sections for 223,225Ra, 225Ac and 227Th production by the proton bombardment of natural thorium targets were measured at proton energies below 200 MeV. Our measurements are in good agreement with previously published data and offer a…
Targeted alpha-particle therapy (TAT) employs alpha-emitting radionuclides conjugated to tumor-targeting molecules to deliver localized radiation to cancer cells, showing great promise in treating metastatic cancers. Among these…
We recommended a new method from different perspective for the production of Ac-227, Ra-228, Th-228 and U-232 radioisotopes which have an important potential for use in radioisotope power systems (instead of Pu-238) and nuclear batteries,…
We present a nitrogen-targeting-Proton-Carbon-Alpha-Therapy method, abbreviated as Proton-CAT, which partially converts protons into carbon-12 and $\alpha$ particles through nuclear reactions between protons and nitrogen-15. Monte Carlo…
Proton (and ion) cancer therapy has proven to be an extremely effective even supe-rior method of treatment for some tumors 1-4. A major problem, however, lies in the cost of the particle accelerator facilities; high procurement costs…
The production of 225Ac using either a proton or electron accelerator requires a target of 226Ra. Radium metal is difficult to work with and so a radium salt, such as radium carbonate, is preferred as a target material. Normally available…
Targeted alpha-particle therapy (TAT) has great promise as a cancer treatment. Arguably the most promising TAT radionuclide that has been proposed is $^{225}$Ac. The development of $^{225}$Ac-based radiopharmaceuticals has been hampered due…
During proton therapy, the beam flux decreases due to inelastic interactions with nuclei. At the highest energies used in proton therapy around 25\% protons initiate nuclear reactions. This report presents the cross section measurements of…
The energy spectrum of alpha particles from the nuclear reaction p + $^{11}$B $\rightarrow 3\alpha$ was studied using the beam of the injector of the proton synchrotron of the Prometheus proton therapy complex. The reaction products (alpha…
We propose a series of simulations about the potential use of Boron isotopes to trigger neutron-free (aneutronic) nuclear reactions in cancer cells through the interaction with an incoming energetic proton beam, thus resulting in the…
The experimental cross sections of Pa-230 formation in the reaction 232Th(p,3n)230Pa for the protons energy range of 140-35 MeV are determined and compared with literature data. The yield of U-230 and impurities of U-232 and U-233 depending…
The decay of instable nuclei is being used in a broad range of applications from detector calibration to power sources. As the public acceptance of classical fission nuclear technology is decaying and its integral costs are enormous,…
The accelerator for the APT Project is a 100 mA CW proton linac with an output energy of 1030 MeV. A High Energy Beam Transport (HEBT) conveys the beam to a raster expander, that provides a large rectangular distribution at a target/blanket…
Targeted Radionuclide Therapy (TRT) is a well-established technique for cancer treatment. In this approach, radionuclides are bound to specific drugs that selectively transport them to the tumor site. Within the ISOLPHARM project, a…
Nuclear formation cross sections are reported for 26 radionuclides, measured with 40 to 200 MeV proton irradiations of terbium foils. These data are relevant to the production of medically relevant radionuclides (e.g., 152Tb, 155Tb, 155Eu,…
Laser acceleration promises innovation in particle beam therapy of cancer where an ultra-compact accelerator system for cancer beam therapy can become affordable to a broad range of patients. This is not feasible without the introduction of…
In order to fulfil the recent thrust of Astatine radionuclides in the field of nuclear medicine various production routes have been explored in the present work. The possible production routes of $^{209-211}$At comprise both light and heavy…
Intensity-modulated proton therapy (IMPT) employs proton radiation rather than conventional X-rays to treat cancerous tumors. This approach offers significant advantages by minimizing the radiation exposure of surrounding healthy tissue,…